Welcome Guest!  Login | Register | Help
Home News Screener Maps Groups Portfolio Insider Futures Forex Collaborate Store Elite
INSM [NASD]
Insmed Incorporated
Index- P/E- EPS (ttm)-1.53 Insider Own1.63% Shs Outstand31.80M Perf Week30.54%
Market Cap346.62M Forward P/E- EPS next Y-1.71 Insider Trans21.01% Shs Float31.48M Perf Month51.39%
Income-41.37M PEG- EPS next Q-0.36 Inst Own51.35% Short Float4.27% Perf Quarter76.38%
Sales0.00M P/S- EPS this Y47.14% Inst Trans5.36% Short Ratio6.02 Perf Half Y46.31%
Book/sh3.41 P/B3.20 EPS next Y14.00% ROA-28.20% Target Price14.25 Perf Year260.93%
Cash/sh2.85 P/C3.82 EPS next 5Y- ROE-32.43% 52W Range2.69 - 11.25 Perf YTD62.93%
Dividend- P/FCF- EPS past 5Y0.00% ROI-30.29% 52W High3.38% Beta0.01
Dividend %- Quick Ratio- Sales past 5Y- Gross Margin- 52W Low332.34% ATR0.67
Employees41 Current Ratio5.94 Sales Q/Q-100.00% Oper. Margin- RSI (14)77.81 Volatility8.80% 7.86%
OptionableYes Debt/Eq0.16 EPS Q/Q-50.06% Profit Margin- Rel Volume3.43 Prev Close10.90
ShortableYes LT Debt/Eq0.13 EarningsMay 07 BMO Payout- Avg Volume223.47K Price11.63
Recom1.30 SMA2027.61% SMA5046.87% SMA20086.80% Volume766,228 Change6.70%
16-Sep-11Initiated Wedbush Outperform $15
16-May-13 06:03PM  Nasdaq stocks posting largest percentage increases AP
01:29PM  Nasdaq stocks posting largest percentage increases AP
15-May-13 06:02PM  Nasdaq stocks posting largest percentage increases AP +16.41%
02:55PM  Insmed rises as analyst forecasts gains for stock AP
01:27PM  Nasdaq stocks posting largest percentage increases AP
08:31AM  2 BioPharma Catalyst Trades And 1 Strong Acquisition Target Rumored To Be In Play at Seeking Alpha
14-May-13 08:10PM  4 Healthcare Stock Stories For Tuesday Investment Wellness at Wall St. Cheat Sheet
10:01AM  Significant Near-Term Top-Line Data Catalyst And Platform Technology Should Propel Insmed at Seeking Alpha
08:01AM  InPlay: Insmed granted key composition of matter patent allowance for ARIKACE in Europe Briefing.com
08:00AM  Insmed Granted Key Composition of Matter Patent Allowance for ARIKACE in Europe Marketwired
08:00AM  Insmed Granted Key Composition of Matter Patent Allowance for ARIKACE in Europe Marketwire
13-May-13 08:00AM  Insmed to Present at the UBS Global Healthcare Conference Marketwired +6.23%
08:00AM  Insmed to Present at the UBS Global Healthcare Conference Marketwire
10-May-13 01:04PM  INSMED INC Financials EDGAR Online Financials
12:52PM  Insmed to Present at the Bank of America Merrill Lynch 2013 Health Care Conference Marketwired
12:52PM  Insmed to Present at the Bank of America Merrill Lynch 2013 Health Care Conference Marketwire
07-May-13 10:41PM  Insmed's CEO Discusses Q1 2013 Results - Earnings Call Transcript at Seeking Alpha
08:30AM  Insmed Incorporated Earnings Call scheduled for 8:30 am ET today CCBN
07:30AM  Insmed Reports First Quarter Financial Results Marketwired
07:30AM  Insmed Reports First Quarter Financial Results Marketwire
07:07AM  Q1 2013 Insmed Incorporated Earnings Release - Before Market Open CCBN
12:35AM  INSMED INC Files SEC form 8-K, Results of Operations and Financial Condition, Financial Statements and Exhibits EDGAR Online
12:32AM  INSMED INC Files SEC form 10-Q, Quarterly Report EDGAR Online
01-May-13 11:29AM  Biotech Stock Value Fundamentally Based on Individual Drug Development and the Competing Landscape: Expert Analyst Boris Peaker Discusses His Coverage of the Biotechnology Sector with The Wall Street Transcript Wall Street Transcript
10:15AM  INSMED INC Files SEC form 8-K, Other Events EDGAR Online
08:00AM  Insmed to Host First Quarter 2013 Financial Results Conference Call on Tuesday, May 7, 2013 Marketwired
08:00AM  Insmed to Host First Quarter 2013 Financial Results Conference Call on Tuesday, May 7, 2013 Marketwire
30-Apr-13 01:03AM  INSMED INC Files SEC form 8-K, Other Events EDGAR Online
25-Apr-13 06:02PM  Nasdaq stocks posting largest percentage increases AP +11.27%
24-Apr-13 06:02PM  Nasdaq stocks posting largest percentage increases AP +17.64%
08:30AM  Quickly Approaching Biopharma Catalyst Events at Seeking Alpha
18-Apr-13 08:00AM  Insmed to Present at the 12th Annual Needham Healthcare Conference Marketwired
08:00AM  Insmed to Present at the 12th Annual Needham Healthcare Conference Marketwire
04-Apr-13 03:43PM  Orphan Status for Insmed's Arikace Zacks
01-Apr-13 04:33PM  Insmed Appoints Matthew Pauls as Chief Commercial Officer Marketwired
04:33PM  Insmed Appoints Matthew Pauls as Chief Commercial Officer Marketwire
09:48AM  INSMED INC Files SEC form 8-K, Regulation FD Disclosure, Financial Statements and Exhibits EDGAR Online
28-Mar-13 04:45PM  4 Healthcare Stock Stories for the End Of The Trading Week at Wall St. Cheat Sheet
08:00AM  InPlay: Insmed announces ARIKACE received orphan drug designation for treating infections caused by non-tuberculous mycobacteria Briefing.com
08:00AM  ARIKACE Receives Orphan Drug Designation for Treating Infections Caused by Non-Tuberculous Mycobacteria Marketwired
08:00AM  ARIKACE Receives Orphan Drug Designation for Treating Infections Caused by Non-Tuberculous Mycobacteria Marketwire
27-Mar-13 08:00AM  Insmed to Present at Future Leaders in the Biotech Industry Conference Marketwired
08:00AM  Insmed to Present at Future Leaders in the Biotech Industry Conference Marketwire
26-Mar-13 10:04AM  On The Fly: Analyst Initiation Summary theflyonthewall.com
22-Mar-13 10:04AM  On The Fly: Analyst Initiation Summary theflyonthewall.com +8.05%
06:23AM  Insmed initiated with a Buy at Canaccord theflyonthewall.com
21-Mar-13 01:04PM  INSMED INC Financials EDGAR Online Financials
18-Mar-13 07:05PM  Insmed Loss Deepens in Q4, Narrows in 2012 at Motley Fool +5.02%
10:50AM  Insmed Incorporated Management Discusses Q4 2012 Results - Earnings Call Transcript at Seeking Alpha
08:30AM  Insmed Incorporated Earnings Call scheduled for 8:30 am ET today CCBN
08:19AM  Insmed Incorporated Earnings Call scheduled for 8:30 am ET today CCBN
07:41AM  Insmed Reports Fourth Quarter and Full Year 2012 Financial Results Marketwire
07:07AM  Q4 2012 Insmed Incorporated Earnings Release - Before Market Open CCBN
12:46AM  INSMED INC Files SEC form 8-K, Results of Operations and Financial Condition, Financial Statements and Exhibits EDGAR Online
12:31AM  INSMED INC Files SEC form 10-K, Annual Report EDGAR Online
15-Mar-13 08:47PM  5 Reasons to Worry About Next Week at Motley Fool
05:30PM  Insmed Earnings: An Early Look at Motley Fool
12-Mar-13 10:01AM  On The Fly: Analyst Initiation Summary theflyonthewall.com
11-Mar-13 10:11AM  On The Fly: Analyst Initiation Summary theflyonthewall.com
08:00AM  Insmed to Host Fourth Quarter and Full Year 2012 Financial Results Conference Call on Monday, March 18, 2013 Marketwire
26-Feb-13 08:00AM  Insmed to Present at Two Upcoming Investor Conferences Marketwire
08-Feb-13 12:50PM  8 Biotech Growth Names: Greg Wade at Seeking Alpha
06-Feb-13 08:00AM  Insmed to Present at Two Upcoming Healthcare Investor Conferences Marketwire
24-Jan-13 08:00AM  Programmed Insider Buying? Yes, at Insmed and United Therapeutics at TheStreet
17-Jan-13 02:06PM  The Law Firm of Levi & Korsinsky, LLP Launches an Investigation into Possible Breaches of Fiduciary Duty by the Board of Directors of Insmed Incorporated in Connection with Executive Compensation PR Newswire
14-Jan-13 11:51AM  Insiders have been buying these stocks at MarketWatch
13-Dec-12 08:00AM  Insmed to Present at 31st Annual J.P. Morgan Healthcare Conference PR Newswire
10-Dec-12 03:14PM  The Best of 2012: Insmed at Motley Fool
05-Dec-12 04:54PM  Wednesday 12/5 Insider Buying Report: TYC, INSM at Forbes
03-Dec-12 07:01AM  INSMED INC Files SEC form 8-K, Regulation FD Disclosure, Financial Statements and Exhibits EDGAR Online
21-Nov-12 11:23AM  3 Stocks Near 52-Week Highs Worth Selling at Motley Fool
16-Nov-12 01:04PM  INSMED INC Financials EDGAR Online Financials
14-Nov-12 08:26AM  Hilltop Holdings Receives Regulatory Approval and 2 Stocks Hitting 52-Week Highs at Wall St. Cheat Sheet
03:35AM  Insmed's CEO Hosts Lazard Capital Markets Healthcare Conference (Transcript) at Seeking Alpha
13-Nov-12 05:52PM  4 Plays Under $10 on the Rise at TheStreet +7.59%
08:37AM  INSMED INC Files SEC form 8-K, Other Events, Financial Statements and Exhibits EDGAR Online
08:07AM  InPlay: Insmed announces CLEAR-108 Phase 3 clinical study of ARIKACE in cystic fibrosis patients with pseudomonas lung infections has completed target enrollment Briefing.com
08:00AM  Insmed Announces CLEAR-108 Phase 3 Clinical Study of ARIKACEĀ® in Cystic Fibrosis Patients with Pseudomonas Lung Infections Has Completed Target Enrollment PR Newswire
12-Nov-12 08:00AM  Insmed To Present At Two Upcoming Investor Conferences PR Newswire
08-Nov-12 04:39PM  The Best Stocks I See In The Market (Part 1) at Seeking Alpha
09:33AM  New Star Analyst Rankings for Insmed, Inc. StarMine
07-Nov-12 04:30PM  Insmed Incorporated Management Discusses Q3 2012 Results - Earnings Call Transcript at Seeking Alpha
03:38PM  CFO Moves: Orbitz, Cornerstone Therapeutics, Insmed at The Wall Street Journal
09:05AM  Insmed Inc. Earnings: Quarterly Loss Narrows at Wall St. Cheat Sheet
08:30AM  Insmed Incorporated Earnings Call scheduled for 8:30 am ET today CCBN
08:16AM  Insmed Incorporated Earnings Call scheduled for 8:30 am ET today CCBN
07:38AM  Insmed Incorporated Earnings Call scheduled for 8:30 am ET today CCBN
07:26AM  INSMED INC Files SEC form 8-K, Results of Operations and Financial Condition, Regulation FD Disclosure, Financial Sta EDGAR Online
07:15AM  Insmed Announces Financial Results for Third Quarter and Nine-Months Ended September 30, 2012 PR Newswire
07:10AM  INSMED INC Files SEC form 8-K, Change in Directors or Principal Officers, Financial Statements and Exhibits EDGAR Online
07:07AM  Q3 2012 Insmed Incorporated Earnings Release - Before Market Open CCBN
07:00AM  Insmed Appoints 15-Year Life Sciences Industry Veteran Andrew Drechsler as Chief Financial Officer PR Newswire
03:14AM  Insmed Third Quarter Earnings Sneak Peek at Wall St. Cheat Sheet
05-Nov-12 10:14AM  Insmed Third Quarter Earnings Sneak Peek at Wall St. Cheat Sheet
02-Nov-12 01:37PM  Insmed Incorporated Third Quarter Earnings Sneak Peek at Wall St. Cheat Sheet
23-Oct-12 05:00PM  NuPathe Announces Closing of $28 Million Private Placement and Changes to Its Board of Directors Marketwire
12-Oct-12 04:45PM  INSMED INC Files SEC form 8-K, Notice of Delisting or Failure to Satisfy a Continued Listing Rule or Standard; Transf EDGAR Online
07-Oct-12 03:53PM  VIVUS Announces Suit Dismissal and 4 Healthcare Stocks in Demand at Wall St. Cheat Sheet
05-Oct-12 06:17PM  Nasdaq stocks posting largest volume increases AP
06:17PM  Nasdaq stocks posting largest percentage increases AP
Insmed Incorporated, a biopharmaceutical company, focuses on developing and commercializing targeted inhalation therapies for patients battling serious lung diseases. Its lead candidate ARIKACE is engineered to deliver a proven and potent anti-infective directly to the site of serious lung infections to improve the treatment for two identified patient populations comprising cystic fibrosis (CF) patients with Pseudomonas aeuruginosa lung infections and patients with nontuberculous mycobacteria lung infections (NTM). The company's Phase III registrational study of ARIKACE in CF patients in Europe and Canada has completed enrollment; and Phase II clinical trial in NTM patients is under way with clinical results. Insmed Incorporated was founded in 1999 and is headquartered in Monmouth Junction, New Jersey.